Our Services in the

At 1.6%, the mortality rate for operations for congenital heart defects was kept at a stable low level in line with the best international standards. Since the mortality statistics also include patients with the use of circulatory support systems, which were mostly used as a bridge to transplantation, and mortality rates for non-cardiac diseases such as lung replacement therapy for acute lung failure, the low mortality rate must be rated as outstanding. The continuous improvements, particularly in palliative surgery for non-correctable heart defects and in the often very complex reoperations, are due to the constant development, adaptation and adherence to in-house standards and guidelines, which, in addition to a uniform treatment strategy, also bring about a significant and sustained improvement in quality and results.

The lethality rate for operations for congenital heart defects is shown in this chart, divided according to age groups. This shows that the intensity of the disease and the complexity of treatment is highest in the newborn under 28 days of life. Nevertheless, a lethality rate of less than 1.0% in the newborn age is exceptionally low. Compared to previous years, the great efforts to maintain standardized procedures and excellently trained personnel seem to be paying off.